Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 14, 2020New England Journal of MedicineOpen Access

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

View Full Paper
Ask AI
Bookmark
Share

Authors

LJLisa A. JacksonKaiser Permanente Washington Health Research InstituteEAEvan J. AndersonEmory UniversityNRNadine RouphaelEmory University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jackson et al. (2020) studied this question.

synapsesocial.com/papers/69d6f19139aaaf0da5ab397dhttps://doi.org/10.1056/nejmoa2022483
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field2018 · 58 citations
  2. 2A review of criteria strictness in “Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials”2023 · 107 citations
  3. 3A proof of concept for structure-based vaccine design targeting RSV in humans2019 · 345 citations
  4. 4SARS-CoV-2 infection protects against rechallenge in rhesus macaques2020 · 930 citations
  5. 5Risk in Vaccine Research and Development Quantified2013 · 269 citations